Our hypothesis was that polymorphisms in the proximal promoter region of CHI3L1, most likely the g.-131(C > G) polymorphism (rs4950928), are associated with serum concentrations of YKL-40 in both patients with RA and healthy controls. Here, CHI3L1 is linked to rheumatoid arthritis.